Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex PharmafiledCriticalVertex Pharma
Priority to TW083110633ApriorityCriticalpatent/TW328085B/en
Application grantedgrantedCritical
Publication of TW328085BpublicationCriticalpatent/TW328085B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A compound of the formula (I) (I) in which: m is 0; B and D each independently are hydrogen or -(CH2)r-(Z)-(CH2)s-Ar, in which: r is 1-3; s is 0-1; Z is CH2; Ar is selected from the group consisting of free phenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl or imidazolyl; R1 is selected from the group consisting of free (C1-C6) linear or branched alkyl, (C1-C6) linear or branched alkyl substituted by imidazolyl, benzyl, or benzyl substituted by halogen; J is (C1-C6) linear or branched alkyl; K is selected from the group consisting of free (C1-C6) linear or branched alkyl, benzyl, benzyl substituted by halogen; and X is 3,4,5-trimethoxyphenyl.
TW083110633A1994-11-161994-11-16Novel amino acid derivatives for the treatment or prevention of multi-drug resistance
TW328085B
(en)